CSIMarket
 


Concert Pharmaceuticals Inc   (CNCE)
Other Ticker:  
 

Concert Pharmaceuticals Inc 's Tangible Leverage Ratio

CNCE's quarterly Tangible Leverage Ratio and Total Liabilities, Tangible Equity growth




CNCE Tangible Leverage Ratio (Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Tangible Equity Change 34.4 % 4.14 % -32.86 % -14.44 % -22.5 %
Y / Y Total Liabilities Change 30.35 % 87.01 % 103.63 % 88.93 % 14.22 %
Tangible Leverage Ratio MRQ 0.28 0.38 0.69 0.47 0.29
Overall Ranking # # # # #
Seq. Tangible Equity Change 4.29 % 66.9 % -31.77 % 13.17 % -19.19 %
Seq. Total Liabilities Change -22.1 % -8.03 % -0.46 % 82.78 % 11.76 %



Tangible Leverage Ratio third quarter 2022 Comment
Due to repayements of liabilities of -22.1% Concert Pharmaceuticals Inc improved Tangible Leverage Ratio in third quarter 2022 to 0.28, above company's average Tangible Leverage Ratio.

Within Major Pharmaceutical Preparations industry Concert Pharmaceuticals Inc achieved lowest Tangible Leverage Ratio. While total ranking remained unchanged compare to previous quarter at no. .

Explain Tangible Leverage Ratio?
What is CNCE Market Share?
Tangible Leverage Ratio third quarter 2022 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #


Tangible Leverage Ratio Statistics
High Average Low
0 0 0
 




Financial Statements
Concert Pharmaceuticals Inc 's Tangible Equity $ 133 Millions Visit CNCE's Balance sheet
Concert Pharmaceuticals Inc 's Total Liabilities $ 38 Millions Visit CNCE's Balance sheet
Source of CNCE's Sales Visit CNCE's Sales by Geography


Cumulative Concert Pharmaceuticals Inc 's Tangible Leverage Ratio

CNCE's Tangible Leverage Ratio for the trailling 12 Months